In addition, we observed that combinatorial treatment reduced the density and percentage of tumor-infiltrating monocytic-myeloid-derived suppressor cells (Mo-MDSC), defined as CD45+CD11b+F4/80+Gr1int cells based on previous reports [27, 28] (Figure 6D). This evidence concerns the gene PTPRC and neoplasm.